The Food and Drug Administration (FDA) on Monday, May 3, clarified that Remdesivir, an investigational drug currently being used in the country on patients with coronavirus disease (COVID-19), has no Certificate of Product Registration (CPR) in the Philippines. Food and Drug Administration (FDA)...
The Philippines is now looking at other suppliers of investigational drugs against the coronavirus disease (COVID-19) as India, a major drug supplier worldwide, is now battling a surge in infections. DOH Undersecretary Maria Rosario Vergeire Health Undersecretary Maria Rosario Vergeire said...
Science-savvy consumer advocacy group Alyansa ng mga Grupong Haligi ng Agham at Teknolohiya Para sa Mamamayan (AGHAM) underscored on Sunday, April 25 a key difference between Ivermectin and Remdesivir, two popular drugs being repurposed for the treatment of the dreaded coronavirus disease...
The Department of Health (DOH) on Friday, April 23 warned the public on the overpricing of Remdesivir. DOH/MB Remdesivir is one of the investigational drugs being used in the Philippines against coronavirus disease (COVID-19). It is currently made available to COVID-19 patients by securing a...